Citations (310)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (44)
Ishika Patel, Li Li, Haelim Jeong, Justin T. McDaniel, Shanna McIntosh, Ellen Robertson & David L. Albright. (2023) Survey of barriers and opportunities for prescribing buprenorphine for opioid use disorder in Alabama. Journal of Addictive Diseases 0:0, pages 1-8.
Read now
Read now
V. B Lushin, E Matthews, V Stanhope, R Rivera, J Rzewinski, R Stewart, J Rees & S Marcus. (2023) Feasibility and acceptability of collaborative documentation tool for implementing medication-assisted treatment in substance use disorder counseling. Journal of Social Work Practice in the Addictions 23:3, pages 179-198.
Read now
Read now
Suzanne M. Grieb, Robert Harris, Amanda Rosecrans, Katie Zook, Susan G. Sherman, Adena Greenbaum, Gregory M. Lucas & Kathleen R. Page. (2022) Awareness, perception and utilization of a mobile health clinic by people who use drugs. Annals of Medicine 54:1, pages 138-149.
Read now
Read now
Aaron R. Brown. (2022) Health professionals’ attitudes toward medications for opioid use disorder. Substance Abuse 43:1, pages 598-614.
Read now
Read now
Frank D. Buono, Rosemary Pickering, Rebecca Berlepsch & Shelley Halligan. (2022) Percutaneous electrical nerve field stimulation to reduce clinical opiate withdrawal: a case series. Journal of Substance Use 27:5, pages 501-504.
Read now
Read now
Matthew LaCasse & Joanna Quigley. (2022) Naltrexone for adolescent opioid use disorder: a bridge in the treatment gap?. Journal of Substance Use 27:3, pages 239-243.
Read now
Read now
Wendy P. Guastaferro, Deborah Koetzle, Laura Lutgen-Nieves & Brent Teasdale. (2022) Opioid Agonist Treatment Recipients within Criminal Justice-Involved Populations. Substance Use & Misuse 57:5, pages 698-707.
Read now
Read now
Juan P. Borda, Hannah Friedman, Jhon Buitrago, Maritza Isaza, Paula Herrera, Noa Krawczyk & Babak Tofighi. (2021) Barriers to treatment for opioid use disorder in Colombia. Journal of Substance Use 26:6, pages 632-638.
Read now
Read now
Ashton E. Clark, Shelby R. Goodwin, Russell M. Marks, Annabelle M. Belcher, Emily Heinlein, Melanie E. Bennett & Daniel J. O. Roche. (2021) A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder. Journal of Dual Diagnosis 17:4, pages 313-332.
Read now
Read now
Sarah Sweeney, Kelly Coble, Elizabeth Connors, Kathleen Rebbert-Franklin, Christopher Welsh & Eric Weintraub. (2021) Program development and implementation outcomes of a statewide addiction consultation service: Maryland Addiction Consultation Service (MACS). Substance Abuse 42:4, pages 595-602.
Read now
Read now
Dana Ripley & Laura E. Welfare. (2021) Reflections on Person-Centered Group Therapy from Clients in Opioid Treatment. The Journal for Specialists in Group Work 46:4, pages 322-338.
Read now
Read now
Michael Fendrich, Jessica Becker, Melissa Ives, Eleni Rodis & Martha Marín. (2021) Treatment Retention in Opioid Dependent Clients Receiving Medication-Assisted Treatment: Six-Month Rate and Baseline Correlates. Substance Use & Misuse 56:7, pages 1018-1023.
Read now
Read now
Lillian MacNeill, Caroline Brunelle, Enrico DiTommaso & Brittany Skelding. (2020) Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT). Journal of Substance Use 25:4, pages 377-381.
Read now
Read now
Jennifer Miles, Jason Howell, Dave Sheridan, George Braucht & Amy Mericle. (2020) Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic. The American Journal of Drug and Alcohol Abuse 46:3, pages 266-272.
Read now
Read now
Jonathan R. Young, Shayan A. Smani, Nicholas A. Mischel, Michael D. Kritzer, Lawrence G. Appelbaum & Ashwin A. Patkar. (2020) Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature. Journal of Addictive Diseases 38:2, pages 186-199.
Read now
Read now
Bennett Allen, Michelle L. Nolan & Denise Paone. (2019) Underutilization of medications to treat opioid use disorder: What role does stigma play?. Substance Abuse 40:4, pages 459-465.
Read now
Read now
Evan Stuart Bradley, David Liss, Stephanie Pepper Carreiro, David Eric Brush & Kavita Babu. (2019) Potential uses of naltrexone in emergency department patients with opioid use disorder. Clinical Toxicology 57:9, pages 753-759.
Read now
Read now
Yang Yang, Julie Gray, George W. Joe, Patrick M. Flynn & Kevin Knight. (2019) Treatment Retention Satisfaction, and Therapeutic Progress for Justice-Involved Individuals Referred to Community-Based Medication-Assisted Treatment. Substance Use & Misuse 54:9, pages 1461-1474.
Read now
Read now
Rachel P. Winograd, Ned Presnall, Erin Stringfellow, Claire Wood, Phil Horn, Alex Duello, Lauren Green & Tim Rudder. (2019) The case for a medication first approach to the treatment of opioid use disorder. The American Journal of Drug and Alcohol Abuse 45:4, pages 333-340.
Read now
Read now
Odelia Elkana, Miriam Adelson, Glen M. Doniger, Anat Sason & Einat Peles. (2019) Cognitive function is largely intact in methadone maintenance treatment patients. The World Journal of Biological Psychiatry 20:3, pages 219-229.
Read now
Read now
Steven L. Proctor, Philip L. Herschman, Ronnie Lee & Albert M. Kopak. (2019) The Role of Patient Payment Method in Premature Discharge from Methadone Maintenance Treatment. Substance Use & Misuse 54:1, pages 97-105.
Read now
Read now
Yara Mouhamed, Andrey Vishnyakov, Bessi Qorri, Manpreet Sambi, SM Signy Frank, Catherine Nowierski, Anmol Lamba, Umrao Bhatti & Myron R Szewczuk. (2018) Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. Drug, Healthcare and Patient Safety 10, pages 45-66.
Read now
Read now
S. E. Streisel. (2018) Intent to Refer: Exploring Bias Toward Specific Medication-Assisted Treatments by Community Corrections Employees. Substance Use & Misuse 53:14, pages 2421-2430.
Read now
Read now
Noa Krawczyk, Tianna Negron, Maia Nieto, Deborah Agus & Michael I. Fingerhood. (2018) Overcoming medication stigma in peer recovery: A new paradigm. Substance Abuse 39:4, pages 404-409.
Read now
Read now
J. H. Ivers, F. Larkan & J. Barry. (2018) A Longitudinal Qualitative Analysis of the Lived Experience of the Recovery Process in Opioid-Dependent Patients Post-Detoxification. Journal of Psychoactive Drugs 50:3, pages 231-239.
Read now
Read now
Sarah E. Wakeman & Josiah D. Rich. (2018) Barriers to Medications for Addiction Treatment: How Stigma Kills. Substance Use & Misuse 53:2, pages 330-333.
Read now
Read now
Nicolas Franchitto, Benedicte Jullian, Juliette Salles, Fanny Pelissier & Benjamin Rolland. (2017) Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians. Expert Opinion on Drug Metabolism & Toxicology 13:6, pages 669-677.
Read now
Read now
Hamid Tavakoli Ghouchani, Shamsedin Niknami, Farkhondeh Aminshokravi & Seyd Kaveh Hojjat. (2017) Effectiveness of the video-based education in the retention of addiction treatment. Journal of Substance Use 22:3, pages 253-259.
Read now
Read now
Jill Littrell. (2017) Expanding access to Medication Assisted Treatment: The U.S. government’s response to the current heroin epidemic. Social Work in Mental Health 15:2, pages 209-229.
Read now
Read now
Ylva Melin, Margita Eklund & Britt-Marie Lindgren. (2017) Experiences of Living With Opioid Dependence: An Interview Study Among Individuals Participating in Medication-Assisted Treatment. Issues in Mental Health Nursing 38:1, pages 9-17.
Read now
Read now
Sunil Sirohi & Amit K Tiwari. (2016) Pain in the management of opioid use disorder. Journal of Pain Research 9, pages 963-966.
Read now
Read now
Christopher S. Stauffer, Vivek Musinipally, Angela Suen, Kara L. Lynch, Brad Shapiro & Joshua D. Woolley. (2016) A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addiction Research & Theory 24:6, pages 490-498.
Read now
Read now
Kai MacDonald, Kristy Lamb, Michael L. Thomas & Wendy Khentigan. (2016) Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices. Substance Use & Misuse 51:1, pages 85-90.
Read now
Read now
Christine Timko, Nicole R. Schultz, Michael A. Cucciare, Lisa Vittorio & Christina Garrison-Diehn. (2016) Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases 35:1, pages 22-35.
Read now
Read now
H. A. Colon-Rivera, A. M. Daum & Sherry Nykiel. (2016) The impact of sharing: The use of shared medical appointments to allow providers to increase treatment access for substance use and related disorders. Substance Abuse 37:1, pages 7-8.
Read now
Read now
Annette Dale-Perera, Farrukh Alam & Peter Barker. (2015) Opioid-dependence treatment in the era of recovery: insights from a UK survey of physicians, patients and out-of-treatment opioid users. Journal of Substance Use 20:5, pages 354-362.
Read now
Read now
David M. Novick, Edwin A. Salsitz, Herman Joseph & Mary Jeanne Kreek. (2015) Methadone Medical Maintenance: An Early 21st-Century Perspective. Journal of Addictive Diseases 34:2-3, pages 226-237.
Read now
Read now
Björn Johnson & Torkel Richert. (2015) Diversion of Methadone and Buprenorphine from Opioid Substitution Treatment: Patients who Regularly Sell or Share Their Medication. Journal of Addictive Diseases 34:1, pages 1-17.
Read now
Read now
Adam Yasgar & Anton Simeonov. (2014) Current approaches for the discovery of drugs that deter substance and drug abuse. Expert Opinion on Drug Discovery 9:11, pages 1319-1331.
Read now
Read now
Stefan Gutwinski, Lena Karoline Bald, Jürgen Gallinat, Andreas Heinz & Felix Bermpohl. (2014) Why do Patients Stay in Opioid Maintenance Treatment?. Substance Use & Misuse 49:6, pages 694-699.
Read now
Read now
Michael I. Fingerhood, Van L. King, Robert K. Brooner & Darius A. Rastegar. (2014) A Comparison of Characteristics and Outcomes of Opioid-Dependent Patients Initiating Office-Based Buprenorphine or Methadone Maintenance Treatment. Substance Abuse 35:2, pages 122-126.
Read now
Read now
William L. White, Michael D. Campbell, Robert D. Spencer, Howard A. Hoffman, Brian Crissman & Robert L. DuPont. (2014) Patterns of Abstinence or Continued Drug Use Among Methadone Maintenance Patients and Their Relation to Treatment Retention. Journal of Psychoactive Drugs 46:2, pages 114-122.
Read now
Read now
Alireza Salimi, Farhad Safari, Seyed
Amir Mohajerani, Morteza Hashemian, Ali-Asghar Kolahi & Kamran Mottaghi. (2014) Long-Term Relapse of Ultra-Rapid Opioid Detoxification. Journal of Addictive Diseases 33:1, pages 33-40.
Read now
Read now
David E Moody. (2013) Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine. Expert Opinion on Drug Metabolism & Toxicology 9:6, pages 675-697.
Read now
Read now
Articles from other publishers (266)
Joshua B. Borris, Caitlin Dowd-Green, Lindsay A. Bowman, Suzanne A. Nesbit, Michael Fingerhood & Rosalyn W. Stewart. (2024) Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone. Journal of Substance Use and Addiction Treatment 156, pages 209209.
Crossref
Crossref
Mary M. Mitchell, Sahil Angelo, Olusegun G. Akinwolere, Molly M. Perkins & Alexis A. Bender. (2024) Latent class analysis of perceived stigma among older adults receiving medications for opioid use disorder. Journal of Substance Use and Addiction Treatment 156, pages 209187.
Crossref
Crossref
Claradina Soto, Kimberly Miller, Lou Moerner, VyVy Nguyen & Guadalupe G. Ramos. (2023) Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation. Journal of Substance Use and Addiction Treatment 155, pages 209115.
Crossref
Crossref
Rachel P. Winograd, Bridget Coffey, Melissa Nance & Ryan Carpenter. (2023) The association of medical providers’ attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices. Addictive Behaviors Reports 18, pages 100514.
Crossref
Crossref
James C. Miller, Michael A. Brooks, Kelly E. Wurzel, Emily J. Cox & John F. WurzelIIIIII. (2023) A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder. Drugs in R&D 23:4, pages 339-362.
Crossref
Crossref
Antonia Young, Pamela Sinicrope, Sydney Kelpin, Anne I. Roche, Corinna Sabaque, Cuong Pham, Lisa A Marsch, Aimee N. C. Campbell, Kamilla Venner, Emily Bastian, Teresa Nord, Gail Mason, Laiel Baker, Thomas Wyatt, Amy Fish, Gavin Bart & Christi A. Patten. (2023) Wiidookaage’Win: A Community-Based Qualitative Approach to Developing a Facebook Group Intervention for Native Women to Support Recovery From Opioid Use. American Journal of Health Promotion.
Crossref
Crossref
Lorenza Colzato, Julia Elmers, Xiaolei Xu, Qiang Zhou, Bernhard Hommel & Christian Beste. (2023) Regaining control over opioid use? The potential application of auricular transcutaneous vagus nerve stimulation to improve opioid treatment in China. Addiction Biology 28:11.
Crossref
Crossref
Peter D. Vu, Vishal Bansal, Ahish Chitneni, Christopher L. Robinson, Omar Viswanath, Ivan Urits, Alan D. Kaye, Anvinh Nguyen, Ranganathan Govindaraj, Grant H. Chen & Jamal Hasoon. (2023) Buprenorphine for Chronic Pain Management: a Narrative Review. Current Pain and Headache Reports.
Crossref
Crossref
Chao Cai, Sophia Knudsen & Kyle Weant. (2023) OPIOID PRESCRIBING BY EMERGENCY PHYSICIANS: TRENDS STUDY OF MEDICARE PART D PRESCRIBER DATA 2013–2019. The Journal of Emergency Medicine.
Crossref
Crossref
Justin R. Jordan, Laura E. Welfare & Matthew C. Fullen. (2023) The influence of professional identity on perceptions of substance use harm reduction among professional counselors. Journal of Addictions & Offender Counseling 44:2, pages 113-131.
Crossref
Crossref
Martin Hochheimer, Jennifer L. Glick, Henri Garrison-Desany & Andrew S. Huhn. (2023) Transgender individuals are at higher risk for suicidal ideation and preparation than cisgender individuals in substance use treatment. Frontiers in Psychiatry 14.
Crossref
Crossref
Einat Peles, Yuli Kim, Anat Sason, Miriam Adelson & Orna Levran. (2023) Predictors of treatment retention and survival among methadone-maintained patients: A possible role for a functional delta opioid receptor gene variant. Drug and Alcohol Dependence 250, pages 110903.
Crossref
Crossref
Sarah E. Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe & Robert S. Kaplan. (2023) A Cost Model for a Low-Threshold Clinic Treating Opioid Use Disorder. The Journal of Behavioral Health Services & Research.
Crossref
Crossref
Katja Troberg, Martin Bråbäck, Pernilla Isendahl, Suzan Nilsson, Disa Dahlman & Anders Håkansson. (2023) Malmö Treatment Referral and Intervention Study (MATRIS)—36-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment—The role of stimulant use at baseline. Journal of Substance Use and Addiction Treatment 151, pages 209036.
Crossref
Crossref
Bethany Crouse, Shannon M. Miller, Peter Muelken, Linda Hicks, Jennifer R. Vigliaturo, Cheryl L. Marker, Alonso G. P. Guedes, Paul R. Pentel, Jay T. Evans, Mark G. LeSage & Marco Pravetoni. (2023) A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. npj Vaccines 8:1.
Crossref
Crossref
Caleb J. Browne, Rita FutamuraAngélica Minier-Toribio, Emily M. Hicks, Aarthi Ramakrishnan, Freddyson J. Martínez-Rivera, Molly EstillArthur Godino, Eric M. Parise, Angélica Torres-Berrío, Ashley M. Cunningham, Peter J. HamiltonDeena M. Walker, Laura M. Huckins, Yasmin L. Hurd, Li Shen & Eric J. Nestler. (2023) Transcriptional signatures of heroin intake and relapse throughout the brain reward circuitry in male mice. Science Advances 9:23.
Crossref
Crossref
Riley McNair, Mark Monaghan & Paul Montgomery. (2023) Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review. Drug and Alcohol Dependence 247, pages 109869.
Crossref
Crossref
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif & Gerard J Marek. (2023)
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABA
B
receptor, and morphine in recreational opioid users
. Journal of Psychopharmacology 37:5, pages 449-461.
Crossref
Crossref
Michele Stanislaw Milella, Ginevra D’Ottavio, Silvana De Pirro, Massimo Barra, Daniele Caprioli & Aldo Badiani. (2023) Heroin and its metabolites: relevance to heroin use disorder. Translational Psychiatry 13:1.
Crossref
Crossref
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, Abhisheak Sharma, Lance R. McMahon & Christopher R. McCurdy. (2023) Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders. Current Addiction Reports 10:2, pages 304-316.
Crossref
Crossref
Lauren J. Tanz, Christopher M. Jones, Nicole L. Davis, Wilson M. Compton, Grant T. Baldwin, Beth Han & Nora D. Volkow. (2023) Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic. JAMA Network Open 6:1, pages e2251856.
Crossref
Crossref
Ariel T. Amgott-Kwan & James E. Zadina. (2023) Endomorphin analog ZH853 shows low reward, tolerance, and affective-motivational signs of withdrawal, while inhibiting opioid withdrawal and seeking.. Neuropharmacology, pages 109439.
Crossref
Crossref
Anne Marciuch, Ida Halvorsen Brenna, Bente Weimand, Kristin Klemmetsby Solli, Lars Tanum, Bente K. Røstad & Bente Birkeland. (2022) Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Piyusha P. Pagare, Samuel Obeng, Boshi Huang, Madison M. Marcus, Katherine L. Nicholson, Andrew E. Townsend, Matthew L. Banks & Yan Zhang. (2022) Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment. ACS Pharmacology & Translational Science 5:11, pages 1197-1209.
Crossref
Crossref
Fengrong Chen, Yu Xu, Kai Shi, Zunyue Zhang, Zhenrong Xie, Hongjin Wu, Yuru Ma, Yong Zhou, Cheng Chen, Jiqing Yang, Yuan Wang, Trevor W. Robbins, Kunhua Wang & Juehua Yu. (2022) Multi-omics study reveals associations among neurotransmitter, extracellular vesicle-derived microRNA and psychiatric comorbidities during heroin and methamphetamine withdrawal. Biomedicine & Pharmacotherapy 155, pages 113685.
Crossref
Crossref
Matthew B. Pomrenze, Daniel F. Cardozo Pinto, Peter A. Neumann, Pierre Llorach, Jason M. Tucciarone, Wade Morishita, Neir Eshel, Boris D. Heifets & Robert C. Malenka. (2022) Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal. Neuron.
Crossref
Crossref
Cindy Parks Thomas, Maureen T. Stewart, Cynthia Tschampl, Kumba Sennaar, Daniel Schwartz & Judith Dey. (2022) Emergency department interventions for opioid use disorder: A synthesis of emerging models. Journal of Substance Abuse Treatment 141, pages 108837.
Crossref
Crossref
Mahtab Razlansari, Fulden Ulucan-Karnak, Masoud Kahrizi, Shekoufeh Mirinejad, Saman Sargazi, Sachin Mishra, Abbas Rahdar & Ana M. Díez-Pascual. (2022) Nanobiosensors for detection of opioids: A review of latest advancements. European Journal of Pharmaceutics and Biopharmaceutics 179, pages 79-94.
Crossref
Crossref
David Adzrago, Angela Di Paola, Jialing Zhu, Alejandro Betancur & J. Michael Wilkerson. (2022) Association between Prescribers’ Perceptions of the Utilization of Medication for Opioid Use Disorder and Opioid Dependence Treatability. Healthcare 10:9, pages 1733.
Crossref
Crossref
Shuhui Jia, Xuantong Guo, Zuxin Chen, Shupeng Li & Xin-an Liu. (2022) The roles of the circadian hormone melatonin in drug addiction. Pharmacological Research 183, pages 106371.
Crossref
Crossref
Selena Gilles. (2022) Opioid Overdose Harm Prevention. Nursing Clinics of North America 57:3, pages 477-488.
Crossref
Crossref
Yvon Yeo, Rosemary Johnson & Christine Heng. (2022) The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths. Military Medicine 187:9-10, pages 244-247.
Crossref
Crossref
Kevin Kavanagh, Kimberly Tallian, Joe A. Sepulveda, Sarah Rojas, Shedrick Martin & Harminder Sikand. (2022) Do buprenorphine doses and ratios matter in medication assisted treatment adherence?. Mental Health Clinician 12:4, pages 241-246.
Crossref
Crossref
Claire A. Wood, Alex Duello, Jennifer Miles, Brenna Lohmann, Tatiana Gochez-Kerr, Kori Richardson, Rosie Anderson-Harper & Rachel P. Winograd. (2022) Acceptance of medications for opioid use disorder in recovery housing programs in Missouri. Journal of Substance Abuse Treatment 138, pages 108747.
Crossref
Crossref
Penelope Mitchell, Steven Samsel, Kevin M. Curtin, Ashleigh Price, Daniel Turner, Ryan Tramp, Matthew Hudnall, Jason Parton & Dwight Lewis. (2022) Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior. Social Science & Medicine 302, pages 114992.
Crossref
Crossref
Leila Mohammadzadeh, Amir Mohammad Alizadeh, Mohammad Sadegh Feiz, Shole Jamali, Mohaddeseh Abedi, Hamid Latifi & Abbas Haghparast. (2022) Acute morphine administration, morphine dependence, and naloxone-induced withdrawal syndrome affect the resting-state functional connectivity and Local Field Potentials of the rat prefrontal cortex. Behavioural Brain Research 427, pages 113859.
Crossref
Crossref
Kayla Joyal, Alyssa M. Peckham, Sarah E. Wakeman, Daniel Zlotoff, Gregory D. Lewis, David D’Alessandro, Jerome C. Crowley & Georgina Waldman. (2021) Management of Opioid Agonist Treatment for Opioid Use Disorder in the Setting of Solid Organ Transplant. Transplantation 106:5, pages 900-903.
Crossref
Crossref
Yang Lv, Man-yi Jing, Pei-yun Li, Tai-yun Zhao, Chong Pang, Guan-yi Lu, Zhi-yuan Wang, Ning Wu, Gang Hu, Rui Song & Jin Li. (2022) Aquaporin-4 deletion attenuates opioid-induced addictive behaviours associated with dopamine levels in nucleus accumbens. Neuropharmacology 208, pages 108986.
Crossref
Crossref
Treah Haggerty, Maryam Khodaverdi, Patricia Dekeseredy, Nathan Wood, Brian Hendricks, Jason Peklinsky & Cara L. Sedney. (2022) Assessing the impact of social distancing measures implemented during COVID-19 pandemic on medications for opioid use disorder in West Virginia. Journal of Substance Abuse Treatment 136, pages 108687.
Crossref
Crossref
Ida Halvorsen Brenna, Anne Marciuch, Bente Birkeland, Marius Veseth, Bente Røstad, Else-Marie Løberg, Kristin Klemmetsby Solli, Lars Tanum & Bente Weimand. (2022) ‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study. Journal of Substance Abuse Treatment 136, pages 108667.
Crossref
Crossref
Michael D. Stein, Donnell VanNoppen, Debra S. Herman, Bradley J. Anderson, Micah Conti & Genie L. Bailey. (2022) Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine. Journal of Substance Abuse Treatment 136, pages 108661.
Crossref
Crossref
Evin Yucel, Benjamin Bearnot, Molly L. Paras, Emily K. Zern, David M. Dudzinski, Chen-Pang Soong, Arminder S. Jassar, Kenneth Rosenfield, Jaclynne Lira, Eugene Lambert, Sarah E. Wakeman & Thoralf Sundt. (2022) Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs. Journal of the American College of Cardiology 79:20, pages 2037-2057.
Crossref
Crossref
Caty SimonLouise VincentAbby CoulterZach SalazarNick VoylesLindsay RobertsDavid FrankSarah Brothers. (2022) The Methadone Manifesto: Treatment Experiences and Policy Recommendations From Methadone Patient Activists. American Journal of Public Health 112:S2, pages S117-S122.
Crossref
Crossref
Hansel Tookes, Jessica Ucha, Allan E. Rodriguez, Edward Suarez, Elizabeth Alonso, Lisa R. Metsch, Daniel J. Feaster, Tyler S. Bartholomew, Kim A. Hoffman & P. Todd Korthuis. (2021) Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study. The Journal of Behavioral Health Services & Research 49:2, pages 240-251.
Crossref
Crossref
Piyusha P. Pagare, Mengchu Li, Yi Zheng, Abhishek S. Kulkarni, Samuel Obeng, Boshi Huang, Christian Ruiz, James C. Gillespie, Rolando E. Mendez, David L. Stevens, Justin L. Poklis, Matthew S. Halquist, William L. Dewey, Dana E. Selley & Yan Zhang. (2022) Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists. Journal of Medicinal Chemistry 65:6, pages 5095-5112.
Crossref
Crossref
Sarah E. Wakeman. (2022) Opioid Use Disorder Diagnosis and Management. NEJM Evidence 1:4.
Crossref
Crossref
Elizabeth Wambui Ngarachu, Sarah Kanana Kiburi, Frederick R. Owiti & Rachel Kangethe. (2022) The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
Jordan R. Kelsch, Abby M. Bailey, Regan A. Baum, Elise L. Metts & Kyle A. Weant. (2021) Guidance for emergency medicine pharmacists to improve care for people with opioid use disorder. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:2, pages 214-227.
Crossref
Crossref
Nadine Hamieh, Alexis Descatha, Marie Zins, Marcel Goldberg, Sébastien Czernichow, Nicolas Hoertel, Marie Plessz, Yves Roquelaure, Frédéric Limosin, Cédric Lemogne, Joane Matta & Guillaume Airagnes. (2022) Physical exertion at work and addictive behaviors: tobacco, cannabis, alcohol, sugar and fat consumption: longitudinal analyses in the CONSTANCES cohort. Scientific Reports 12:1.
Crossref
Crossref
Martin Bråbäck, Anna Brantefors, Johan Franck, Louise Brådvik, Pernilla Isendahl, Suzan Nilsson, Katja Troberg & Anders Håkansson. (2022) Substance Use, Hospitalizations, and Co-Occurring Disorders among Patients Transferred from a Needle Exchange Program to Opioid Maintenance Treatment. International Journal of Environmental Research and Public Health 19:2, pages 697.
Crossref
Crossref
Luisa Fernanda Vélez-Tovar, Evelyn Judith Cruz-Nocelo, María Concepción Serratos-Vázquez & Víctor Hugo Zúñiga-Carmona. (2022) Tratamiento del dolor agudo por lesión traumática en pacientes con adicciones. Revista Mexicana de Anestesiología 45:2, pages 107-113.
Crossref
Crossref
Kari Bøhle, Eli Otterholt & Stål Bjørkly. (2022) Is There an Association Between Salivary Cortisol and Dropping Out of Inpatient Substance Addiction Treatments? A Prospective Repeated Measures Study. Substance Abuse: Research and Treatment 16, pages 117822182211067.
Crossref
Crossref
Yen-Jung Chen, Ju-Ting Lu, Chun-Wei Huang, Wei-Hsin Wu, Kuei-Fang Lee, Hsin-Tzu Liu & Lawrence Shih-Hsin Wu. (2021) Pharmacogenetic study of methadone treatment for heroin addiction: associations between drug-metabolizing gene polymorphisms and treatment efficacy. Pharmacogenetics and Genomics 32:1, pages 31-38.
Crossref
Crossref
Martin Hochheimer & George Jay Unick. (2022) Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States. Addictive Behaviors 124, pages 107113.
Crossref
Crossref
Heino Stöver, Jörg Pont, Hans Wolff & Stefan Enggist. 2022. Human Rights Behind Bars. Human Rights Behind Bars
245
264
.
Sierra Ferguson & Aviva Teitelbaum. 2022. Addiction Medicine. Addiction Medicine
67
79
.
David P. Graham, Mark J. Harding & David A. Nielsen. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
437
490
.
Amber N. Edinoff, Catherine A. Nix, Claudia V. Orellana, Samantha M. StPierre, Erin A. Crane, Blaine T. Bulloch, Elyse M. Cornett, Rachel L. Kozinn, Adam M. Kaye, Kevin S. Murnane & Alan D. Kaye. (2021) Naltrexone Implant for Opioid Use Disorder. Neurology International 14:1, pages 49-61.
Crossref
Crossref
Fatemeh Chalabianloo, Lars Thore Fadnes, Gudrun Høiseth, Christian Ohldieck, Jørn Henrik Vold, Christer Aas, Else-Marie Løberg, Kjell Arne Johansson & Jørgen G. Bramness. (2021) Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Sun Tun, B. Vicknasingam & Darshan Singh. (2021) Factors affecting addiction severity index (ASI) among clients enrolled in methadone maintenance treatment (MMT) program in Myanmar. Harm Reduction Journal 18:1.
Crossref
Crossref
Ben Houghton, Christos Kouimtsidis, Theodora Duka, Yannis Paloyelis & Alexis Bailey. (2021) Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review. British Journal of Pharmacology 178:21, pages 4316-4334.
Crossref
Crossref
Josephine Palandri, Sharon L Smith, David J Heal, Sue Wonnacott & Chris P Bailey. (2021) Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement. Journal of Psychopharmacology 35:10, pages 1204-1215.
Crossref
Crossref
Lynn Kohan, Sudheer Potru, Antje M Barreveld, Michael Sprintz, Olabisi Lane, Anuj Aryal, Trent Emerick, Anna Dopp, Sophia Chhay & Eugene Viscusi. (2021) Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. Regional Anesthesia & Pain Medicine 46:10, pages 840-859.
Crossref
Crossref
Maureen T. Stewart, Neto Coulibaly, Daniel Schwartz, Judith Dey & Cindy Parks Thomas. (2021) Emergency department–based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches?. Journal of Substance Abuse Treatment 129, pages 108479.
Crossref
Crossref
Margarida L. F. Martins, Erica A. Wilthagen, Eugenia Oviedo-Joekes, Jos H. Beijnen, Nelda de Grave, Ambros Uchtenhagen, Thilo Beck, Wim Van den Brink & Alfred H. Schinkel. (2021) The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review. Drug and Alcohol Dependence 227, pages 108984.
Crossref
Crossref
Jonah D. Stickney & Michael M. Morgan. (2021) Comparative benefits of social housing and buprenorphine on wheel running depressed by morphine withdrawal in rats. Psychopharmacology 238:10, pages 2895-2903.
Crossref
Crossref
Seth Himelhoch, Marion Currens, Jewell Benford & Eric Weintraub. 2021. Leading Community Based Changes in the Culture of Health in the US - Experiences in Developing the Team and Impacting the Community. Leading Community Based Changes in the Culture of Health in the US - Experiences in Developing the Team and Impacting the Community.
Amber N. Edinoff, Leah A. Kaplan, Sami Khan, Murray Petersen, Emily Sauce, Christopher D. Causey, Elyse M. Cornett, Farnad Imani, Omid Moradi Moghadam, Adam M. Kaye & Alan D. Kaye. (2021) Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations. Anesthesiology and Pain Medicine 11:4.
Crossref
Crossref
Lillian MacNeill, Caroline Brunelle, Brittany Skelding & Enrico DiTommaso. (2020) Experiences of Clients in Three Types of Methadone Maintenance Therapy in an Atlantic Canadian City: A Qualitative Study. Canadian Journal of Nursing Research 53:3, pages 211-221.
Crossref
Crossref
Kirsten Lehmann, Silke Kuhn, Cinzia Baschirotto, Britta Jacobsen, Stephan Walcher, Herbert Görne, Markus Backmund, Norbert Scherbaum, Jens Reimer & Uwe Verthein. (2021) Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine. Journal of Substance Abuse Treatment 127, pages 108350.
Crossref
Crossref
E. Andrew Townsend, R. Kijoon Kim, Hannah L. Robinson, Samuel A. Marsh, Matthew L. Banks & Peter J. Hamilton. (2021) Opioid Withdrawal Produces Sex-Specific Effects on Fentanyl-Versus-Food Choice and Mesolimbic Transcription. Biological Psychiatry Global Open Science 1:2, pages 112-122.
Crossref
Crossref
Rahimah Hassan, Sasidharan Sreenivasan, Christian P. Müller & Zurina Hassan. (2021) Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats. Frontiers in Pharmacology 12.
Crossref
Crossref
Shari Rogal, Ada YoukOlufunso AgbalajobiHongwei ZhangWalid GelladMichael J. FinePamela BelperioTimothy MorganChester B. GoodKevin Kraemer. (2021) Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. American Journal of Gastroenterology 116:7, pages 1406-1413.
Crossref
Crossref
Juliane Mielau, Marc Vogel, Stefan Gutwinski & Inge Mick. (2021) New Approaches in Drug Dependence: Opioids. Current Addiction Reports 8:2, pages 298-305.
Crossref
Crossref
Sara Sadat Aghabozorg Afjeh, Behzad Boshehri, Safar Hamednia, Asmaolhosna Amini, Parisa Mashayekhi & Mir Davood Omrani. (2021) Investigating the CYP2B6 rs3745274 and rs3211371 polymorphisms in Methadone-Responder and Non-Responder Addicts in Iran. Iranian Biomedical Journal 25:3, pages 220-225.
Crossref
Crossref
William Vail, Elissa Faro, Dana Watnick, Jonathan Giftos & Aaron D. Fox. (2021) Does incarceration influence patients’ goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail. Drug and Alcohol Dependence 222, pages 108529.
Crossref
Crossref
Lucas dos Reis Izolan, Douglas Marques da Silva, Helena Beatriz Larrosa Oliveira, Janaína Lucas de Oliveira Salomon, Caroline Portela Peruzzi, Solange C. Garcia, Eliane Dallegrave, Caroline Zanotto, Elaine Elisabetsky, Carlos Alberto Gonçalves, Marcelo Dutra Arbo, Eduardo Luis Konrath & Mirna Bainy Leal. (2021) Sintocalmy, a Passiflora incarnata Based Herbal, Attenuates Morphine Withdrawal in Mice. Neurochemical Research 46:5, pages 1092-1100.
Crossref
Crossref
Asif Khan, Qudsia Khan & Elizabeth Kolb. (2021) Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes. Journal of Substance Abuse Treatment 123, pages 108256.
Crossref
Crossref
Sandeep M. Nayak, Andrew S. Huhn, Cecilia L. Bergeria, Eric C. Strain & Kelly E. Dunn. (2021) Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder. Drug and Alcohol Dependence 221, pages 108649.
Crossref
Crossref
Gillian A. Beauchamp, Lexis T. Laubach, Samantha B. Esposito, Ali Yazdanyar, Paige Roth, Priyanka Lauber, Jamie Allen, Nathan Boateng, Samantha Shaak & David B. Burmeister. (2020) Implementation of a Medication for Addiction Treatment (MAT) and Linkage Program by Leveraging Community Partnerships and Medical Toxicology Expertise. Journal of Medical Toxicology 17:2, pages 176-184.
Crossref
Crossref
Tran H Tran, Henry Swoboda, Katy Perticone, Elisabeth Ramsey, Hale Thompson, Kristin Hill & Niranjan S Karnik. (2021) The substance use intervention team: A hospital-based intervention and outpatient clinic to improve care for patients with substance use disorders. American Journal of Health-System Pharmacy 78:4, pages 345-353.
Crossref
Crossref
Mahluga Jafarova Demirkapu. 2021. Medical Toxicology. Medical Toxicology.
Kristen A. Morin, Matthiew D. Parrotta, Joseph K. Eibl & David C. Marsh. (2021) A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data. European Addiction Research 27:4, pages 268-276.
Crossref
Crossref
Einat Peles, Orna Levran, Matthew Randesi, Jurg Ott, Mary Jeanne Kreek & Miriam Adelson. (2021) Polymorphisms in Stress-Related Genes Are Associated with Reduced Cocaine Abuse and Longer Retention in Methadone Maintenance Treatment for Opioid Use Disorder. European Addiction Research 27:3, pages 198-205.
Crossref
Crossref
Tania D. Strout, Michael R. Baumann & Lauren T. Wendell. (2021) Understanding ED Buprenorphine Initiation for Opioid Use Disorder: A Guide for Emergency Nurses. Journal of Emergency Nursing 47:1, pages 139-154.
Crossref
Crossref
Tiffany Lu & Chinazo Cunningham. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings
23
42
.
Kanishka Rajput, Gopal Kodumudi & Nalini Vadivelu. 2021. Pain Control in Ambulatory Surgery Centers. Pain Control in Ambulatory Surgery Centers
309
325
.
John M. Roll, Sterling M. McPherson & Michael G. McDonell. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
417
432
.
Kristen A. Morin, Joseph K. Eibl, Joseph M. Caswell, Brian Rush, Christopher Mushquash, Nancy E. Lightfoot & David C. Marsh. (2020) Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada. PLOS ONE 15:12, pages e0243317.
Crossref
Crossref
Mohammad S. Jalali, Michael Botticelli, Rachael C. Hwang, Howard K. Koh & R. Kathryn McHugh. (2020) The opioid crisis: a contextual, social-ecological framework. Health Research Policy and Systems 18:1.
Crossref
Crossref
Jin-Feng Huang, Zhou Meng, Xuan-Qi Zheng, Zongshi Qin, Xiao-Lei Sun, Kai Zhang, Hai-Jun Tian, Xiao-Bing Wang, Ze Gao, Yan Michael Li & Ai-Min Wu. (2020) Real-World Evidence in Prescription Medication Use Among U.S. Adults with Neck Pain. Pain and Therapy 9:2, pages 637-655.
Crossref
Crossref
Perry Xu, Edward Choi, Farouk M. El-Khatib, Emily Choe & Faysal Yafi. (2020) Sexual Dysfunction in Persons Receiving Opioid Substitution Therapy. Current Sexual Health Reports 12:4, pages 371-380.
Crossref
Crossref
Susan Schenk, Hedwig Eisenbarth & Louise Dixon. (2020) Treating opioid use disorders in the criminal justice system with pharmacotherapy. Forensic Science International: Mind and Law 1, pages 100009.
Crossref
Crossref
Lia N. Pizzicato, Jeffrey K. Hom, Monica Sun, Caroline C. Johnson & Kendra M. Viner. (2020) Adherence to buprenorphine: An analysis of prescription drug monitoring program data. Drug and Alcohol Dependence 216, pages 108317.
Crossref
Crossref
Leigh V. Panlilio, Samuel W. Stull, Jeremiah W. Bertz, Albert J. Burgess-Hull, William J. Kowalczyk, Karran A. Phillips, David H. Epstein & Kenzie L. Preston. (2020) Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials. Psychopharmacology 237:11, pages 3369-3381.
Crossref
Crossref
Chunyuan Huang, Li Ye, Abu S Abdullah, Bingyu Liang, Junjun Jiang, Chuanyi Ning, Ning Zang, Yu Zhang, Yuan Yang, Xi Hu, Quanlue Yang, Chaolian Luo, Feixiang Lao, Huifang Liu, Hao Liang & Jiegang Huang. (2020) No Increase in HIV Drug Resistance Mutations among Injecting Drug Users on Methadone Maintenance Therapy: A Prospective Cohort Study. Current HIV Research 18:5, pages 362-372.
Crossref
Crossref
Elenore P. Bhatraju, Natasha Ludwig-Barron, Julian Takagi-Stewart, Harveen K. Sandhu, Jared W. Klein & Judith I. Tsui. (2020) Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma. Drug and Alcohol Dependence 215, pages 108253.
Crossref
Crossref
Reda M. Chalhoub & Peter W. Kalivas. (2020) Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Drugs 80:15, pages 1509-1524.
Crossref
Crossref
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
Abdolali Moosavyzadeh, Razieh Jafari Hajati, Farzaneh Ghaffari, Shabnam Khatami, Niki Vakili Zahir & Mohsen Naseri. (2020) From Datura stramonium L to Hab-o-shefa: manuscript, animal and clinical studies for the treatment of addiction. Journal of Medicinal Plants 19:75, pages 4-16.
Crossref
Crossref
Cinzia Baschirotto, Kirsten Lehmann, Silke Kuhn, Jens Reimer & Uwe Verthein. (2020) Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care. Journal of Pharmacological Sciences 144:1, pages 9-15.
Crossref
Crossref
Mei-Rong Wang, Di-Di Wu, Fan Luo, Chao-Jie Zhong, Xin Wang, Ni Zhu, Ying-Jun Wu, Hai-Tao Hu, Yong Feng, Xu Wang, Hai-Rong Xiong & Wei Hou. (2020) Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages. Frontiers in Immunology 11.
Crossref
Crossref
Bin Yu, Junmin Zhou, Yi Gong, Jiayu Han, Peijie Dong, Shifan Yang, Rui Liao, Pujun Guan & Shujuan Yang. (2020) Self-efficacy Mediates Perceived Benefits and Barriers of Adherence of Heroin-dependent Patients to Methadone for Addiction Treatment: A Health Belief Model Study. Journal of Addiction Medicine 14:4, pages e110-e117.
Crossref
Crossref
Christine E. Grella, Erika Ostile, Christy K Scott, Michael Dennis & John Carnavale. (2020) A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System. International Journal of Drug Policy 81, pages 102768.
Crossref
Crossref
Valerii Kushnir, Svitlana Dmytrenko, Oleksandr Katilov & Natalia Kushnir. (2020) Itching as the onset of pain (part 3). Pain medicine 5:2, pages 76-85.
Crossref
Crossref
Maria Carmen Blanco-Gandía, Sandra Montagud-Romero & Marta Rodríguez-Arias. 2020. Opioids - From Analgesic Use to Addiction. Opioids - From Analgesic Use to Addiction.
Andrew Stokes, Dielle J. Lundberg, Katherine Hempstead, Kaitlyn M. Berry, Joshua F. Baker & Samuel H. Preston. (2020) Obesity and Incident Prescription Opioid Use in the U.S., 2000–2015. American Journal of Preventive Medicine 58:6, pages 766-775.
Crossref
Crossref
Camille A. Robinson & J. Deanna Wilson. (2020) Management of Opioid Misuse and Opioid Use Disorders Among Youth. Pediatrics 145:Supplement_2, pages S153-S164.
Crossref
Crossref
Bahareh Ebrahimi & Saeed Esmaeili-Mahani. (2020) The Effects of Hydroalcoholic Extract of Satureja khuzestanica on Naloxone-Induced Morphine Withdrawal Symptoms in Wistar Rats. International Journal of Basic Science in Medicine 5:1, pages 16-21.
Crossref
Crossref
David H. Epstein, Matthew Tyburski, William J. Kowalczyk, Albert J. Burgess-Hull, Karran A. Phillips, Brenda L. Curtis & Kenzie L. Preston. (2020) Prediction of stress and drug craving ninety minutes in the future with passively collected GPS data. npj Digital Medicine 3:1.
Crossref
Crossref
Lulu Zhao, Cece Cheng & Lauren Bouchard. (2020) Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Practical Applications and Clinical Impact. Obstetrical & Gynecological Survey 75:3, pages 175-189.
Crossref
Crossref
Michelle Knapp & Selena Gilles. (2020) Compassionate Care of the Patient Who Uses Substances. Journal of Infusion Nursing 43:2, pages 70-77.
Crossref
Crossref
Andrea Jakubowski & Aaron Fox. (2020) Defining Low-threshold Buprenorphine Treatment. Journal of Addiction Medicine 14:2, pages 95-98.
Crossref
Crossref
Michael Stein, Debra Herman, Micah Conti, Bradley Anderson & Genie Bailey. (2019) Initiating buprenorphine treatment for opioid use disorder during short‐term in‐patient ‘detoxification’: a randomized clinical trial. Addiction 115:1, pages 82-94.
Crossref
Crossref
Hongguang Ma, Samuel Obeng, Huiqun Wang, Yi Zheng, Mengchu Li, Abdulmajeed M. Jali, David L. Stevens, William L. Dewey, Dana E. Selley & Yan Zhang. (2019) Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators. Journal of Medicinal Chemistry 62:24, pages 11399-11415.
Crossref
Crossref
Andrew Stokes, Kaitlyn M. Berry, Katherine Hempstead, Dielle J. Lundberg & Tuhina Neogi. (2019) Trends in Prescription Analgesic Use Among Adults With Musculoskeletal Conditions in the United States, 1999-2016. JAMA Network Open 2:12, pages e1917228.
Crossref
Crossref
Jessica Reichert & Lily Gleicher. (2019) Probation clients’ barriers to access and use of opioid use disorder medications. Health & Justice 7:1.
Crossref
Crossref
Paxton Bach & Daniel Hartung. (2019) Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. Addiction Science & Clinical Practice 14:1.
Crossref
Crossref
Heino Stöver, Daniela Jamin, Ingo Ilja Michels, Bärbel Knorr, Karlheinz Keppler & Daniel Deimel. (2019) Opioid substitution therapy for people living in German prisons—inequality compared with civic sector. Harm Reduction Journal 16:1.
Crossref
Crossref
Julia Kriegler, Sophia Wegener, Francois Richter, Norbert Scherbaum, Matthias Brand & Elisa Wegmann. (2019) Decision making of individuals with heroin addiction receiving opioid maintenance treatment compared to early abstinent users. Drug and Alcohol Dependence 205, pages 107593.
Crossref
Crossref
Ying Han, Wei Yan, Yongbo Zheng, Muhammad Zahid Khan, Kai Yuan & Lin Lu. (2019) The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Translational Psychiatry 9:1.
Crossref
Crossref
Brian D. Kiluk, Sarah W. Yip, Elise E. DeVito, Kathleen M. Carroll & Mehmet Sofuoglu. (2019) Anhedonia as a Key Clinical Feature in the Maintenance and Treatment of Opioid Use Disorder. Clinical Psychological Science 7:6, pages 1190-1206.
Crossref
Crossref
David H. Epstein. (2019) Cannabidiol: Not a Cure-All, but a Candidate for Coping With Cue-Induced Craving. American Journal of Psychiatry 176:11, pages 888-891.
Crossref
Crossref
Einat Peles, Orna Levran, Matthew Randesi, Jurg Ott, Mary Jeanne Kreek & Miriam Adelson. (2019) Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction. Journal of Addiction Medicine 13:6, pages 430-435.
Crossref
Crossref
Sarah Kawasaki, Erica Francis, Sara Mills, Glenn Buchberger, Ruth Hogentogler & Jennifer Kraschnewski. (2019) Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. Journal of Substance Abuse Treatment 106, pages 58-64.
Crossref
Crossref
Jeremiah W. Bertz, David H. Epstein, David Reamer, William J. Kowalczyk, Karran A. Phillips, Ashley P. Kennedy, Michelle L. Jobes, Greg Ward, Barbara A. Plitnick, Mariana G. Figueiro, Mark S. Rea & Kenzie L. Preston. (2019) Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy. Journal of Substance Abuse Treatment 106, pages 43-57.
Crossref
Crossref
Elizabeth A. Evans, Caroline Yoo, David Huang, Andrew J. Saxon & Yih-Ing Hser. (2019) Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder. Journal of Substance Abuse Treatment 106, pages 19-28.
Crossref
Crossref
Marthe Fredheim Fjelldal, Mussie Ghezu Hadera, Mette Kongstorp, Lars Peter Engeset Austdal, Ana Šulović, Jannike Mørch Andersen & Ragnhild Elisabeth Paulsen. (2019) Opioid receptor‐mediated changes in the NMDA receptor in developing rat and chicken. International Journal of Developmental Neuroscience 78:1, pages 19-27.
Crossref
Crossref
I.T. Mahu, P.J. Conrod, S.P. Barrett, A. Sako, J. Swansburg, M. Lawrence, F. Laroque, J.F. Morin, A. Chinneck, R. Nogueira-Arjona & S.H. Stewart. (2019) Specificity of personality relationships to particular forms of concurrent substance use among methadone maintenance therapy clients. Addictive Behaviors 98, pages 106056.
Crossref
Crossref
Fatemeh Chalabianloo, Andreas A. Westin, Eirik Skogvoll, Jørgen G. Bramness & Olav Spigset. (2019) Methadone serum concentrations and influencing factors: A naturalistic observational study. Psychopharmacology 236:11, pages 3159-3167.
Crossref
Crossref
Andrew Stokes, Kaitlyn M. Berry, Jason M. Collins, Chia-Wen Hsiao, Jason R. Waggoner, Stephen S. Johnston, Eric M. Ammann, Robin F. Scamuffa, Sonia Lee, Dielle J. Lundberg, Daniel H. Solomon, David T. Felson, Tuhina Neogi & JoAnn E. Manson. (2019) The contribution of obesity to prescription opioid use in the United States. Pain 160:10, pages 2255-2262.
Crossref
Crossref
Concetta Paola Pelullo, Fabio Curcio, Francesco Auriemma, Giuseppe Cefalo, Antonio Fabozzi, Riccardo Rossiello, Laura Spagnoli & Francesco Attena. (2019) The Discrimination Against, Health Status and Wellness of People Who Use Drugs in Italian Services: A Survey. Medicina 55:10, pages 662.
Crossref
Crossref
L Teoh, G Moses & MJ McCullough. (2019) Oral manifestations of illicit drug use. Australian Dental Journal 64:3, pages 213-222.
Crossref
Crossref
P. San Juan Sanz. (2019) Trastorno por consumo de sustancias. Medicine - Programa de Formación Médica Continuada Acreditado 12:85, pages 4984-4992.
Crossref
Crossref
Leigh V. Panlilio, Samuel W. Stull, William J. Kowalczyk, Karran A. Phillips, Jennifer R. Schroeder, Jeremiah W. Bertz, Massoud Vahabzadeh, Jia-Ling Lin, Mustapha Mezghanni, Edward V. Nunes, David H. Epstein & Kenzie L. Preston. (2019) Stress, craving and mood as predictors of early dropout from opioid agonist therapy. Drug and Alcohol Dependence 202, pages 200-208.
Crossref
Crossref
Johan Kakko, Hannu Alho, Alexander Baldacchino, Rocío Molina, Felice Alfonso Nava & Gabriel Shaya. (2019) Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice. Frontiers in Psychiatry 10.
Crossref
Crossref
David A. Wiss. (2019) A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health. Frontiers in Public Health 7.
Crossref
Crossref
S.M. van Rijswijk, M.H.C.T. van Beek, G.M. Schoof, A.H. Schene, M. Steegers & A.F. Schellekens. (2019) Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review. General Hospital Psychiatry 59, pages 37-50.
Crossref
Crossref
Tobias Marton, Deborah E. Barnes, Art Wallace & Joshua D. Woolley. (2019) Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine’s Antidepressant Activity. Biological Psychiatry 85:12, pages e75-e76.
Crossref
Crossref
Samuel Obeng, Abdulmajeed Jali, Yi Zheng, Huiqun Wang, Kathryn L. Schwienteck, Chongguang Chen, David L. Stevens, Hamid I. Akbarali, William L. Dewey, Mathew L. Banks, Lee-Yuan Liu-Chen, Dana E. Selley & Yan Zhang. (2019) Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment. ACS Chemical Neuroscience 10:5, pages 2518-2532.
Crossref
Crossref
Dharushana Muthulingam, Joshua Bia, Lynn M. Madden, Scott O. Farnum, Declan T. Barry & Frederick L. Altice. (2019) Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support. Journal of Substance Abuse Treatment 100, pages 18-28.
Crossref
Crossref
Pallavi Joshi, Nikita K. Shah & Harshal D. Kirane. (2019) Medication-Assisted Treatment for Opioid Use Disorder in Older Adults: An Emerging Role for the Geriatric Psychiatrist. The American Journal of Geriatric Psychiatry 27:4, pages 455-457.
Crossref
Crossref
Steven L. Proctor, Autumn Birch & Philip L. Herschman. (2019) Medication Treatment With Methadone or Buprenorphine: Differential Reasons for Premature Discharge. Journal of Addiction Medicine 13:2, pages 113-118.
Crossref
Crossref
Hestia Moningka, Sarah Lichenstein & Sarah W. Yip. (2019) Current Understanding of the Neurobiology of Opioid Use Disorder: an Overview. Current Behavioral Neuroscience Reports 6:1, pages 1-11.
Crossref
Crossref
Sarah E. Wakeman. (2019) Facing Addiction. Psychiatric Annals 49:2, pages 47-54.
Crossref
Crossref
Fatemeh Nouri, Mohammad Reza Afarinesh, Vahid Sheibani, Alireza Foroumadi, Saeed Esmaeili Mahani, Mostafa Mahmoudi & Ehsan Rohani. (2019) Concomitant abuse of methadone and methamphetamine could impair spatial learning and memory in male rats. Learning and Motivation 65, pages 43-51.
Crossref
Crossref
Christopher J. Shephard & Aaron D. Drovandi. (2019) Sustained‐release subdermal buprenorphine implants: the future of opioid use disorder management?. Journal of Pharmacy Practice and Research 49:1, pages 41-49.
Crossref
Crossref
Yi Zheng, Samuel Obeng, Huiqun Wang, Abdulmajeed M. Jali, Bharath Peddibhotla, Dwight A. Williams, Chuanchun Zou, David L. Stevens, William L. Dewey, Hamid I. Akbarali, Dana E. Selley & Yan Zhang. (2019) Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4′-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands. Journal of Medicinal Chemistry 62:2, pages 561-574.
Crossref
Crossref
K. Paul Rezai-Zadeh, Richard N. Engstrom, Andy Sharma, Yiming Chen, Jun Chu, Robin Parker Cox & Mei-Ling Ting Lee. (2019) Generational trends and patterns in readmission within a statewide cohort of clients receiving heroin use disorder treatment in Maryland, 2007–2013. Journal of Substance Abuse Treatment 96, pages 82-91.
Crossref
Crossref
David H. Cisewski, Cynthia Santos, Alex Koyfman & Brit Long. (2019) Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting. The American Journal of Emergency Medicine 37:1, pages 143-150.
Crossref
Crossref
Elizabeth A. Evans & Yih-Ing Hser. 2019. Treating Opioid Addiction. Treating Opioid Addiction
181
196
.
Aaron D. Fox, Andrea U. Jakubowski & Jonathan Giftos. 2019. Treating Opioid Addiction. Treating Opioid Addiction
197
222
.
Eric Weintraub, Aaron David Greenblatt, Joy Chang, Seth Himelhoch & Christopher Welsh. (2018) Expanding access to buprenorphine treatment in rural areas with the use of telemedicine. The American Journal on Addictions 27:8, pages 612-617.
Crossref
Crossref
Cassie Higgins, Blair H. Smith & Keith Matthews. (2018) Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence. Drug and Alcohol Dependence 193, pages 131-136.
Crossref
Crossref
Yuhui Zhu, Elizabeth A. Evans, Larissa J. Mooney, Andrew J. Saxon, Annamarie Kelleghan, Caroline Yoo & Yih-Ing Hser. (2018) Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. Journal of Neuroimmune Pharmacology 13:4, pages 488-497.
Crossref
Crossref
Tam Nguyen, Bach Tran, Mercerdes Fleming, Manh Pham, Long Nguyen, Huong Le, Anh Nguyen, Huong Le, Thang Nguyen, Van Hoang, Xuan Le, Quan Vuong, Manh Ho, Van Dam, Thu Vuong, Ha Do, Vu Nguyen, Huong Nguyen, Huyen Do, Phuong Doan, Hai Nguyen, Carl Latkin, Cyrus Ho & Roger Ho. (2018) Methadone Maintenance Treatment Reduces the Vulnerability of Drug Users on HIV/AIDS in Vietnamese Remote Settings: Assessing the Changes in HIV Knowledge, Perceived Risk, and Testing Uptake after a 12-Month Follow-Up. International Journal of Environmental Research and Public Health 15:11, pages 2567.
Crossref
Crossref
Displaying 200 of 310 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list